- Related Diseases
- Images & Quizzes
- Breast Cancer Slideshow
- Take the Breast Cancer Quiz
- Breast Cancer Screening
- What is eribulin mesylate, Halaven, and how does it work (mechanism of action)?
- What brand names are available for eribulin mesylate, Halaven?
- Is eribulin mesylate, Halaven available as a generic drug?
- Do I need a prescription for eribulin mesylate, Halaven?
- What are the side effects of eribulin mesylate, Halaven?
- What is the dosage for eribulin mesylate, Halaven?
- Which drugs or supplements interact with eribulin mesylate, Halaven?
- Is eribulin mesylate, Halaven safe to take if I'm pregnant or breastfeeding?
- What else should I know about eribulin mesylate, Halaven?
What is eribulin mesylate, Halaven, and how does it work (mechanism of action)?
Microtubules are dynamic intracellular structures that are responsible for various kinds of movements including cell division, organization of intracellular structure, and intracellular transport. Eribulin inhibits the growth phase of microtubules, consequently interfering with cell growth and function and eventually causing cancer cell death. Eribulin was developed from a chemical first isolated from the rare marine sponge, Halichondria okadai.
Eribulin can help some patients with metastatic breast cancer live longer. In one trial, women treated with eribulin lived about 2.5 months longer than women who received other treatments. Eribulin was approved by the FDA in 2010.
What are the side effects of eribulin mesylate, Halaven?
The most common side effects of eribulin are:
- low white blood cells,
- low red blood cells,
- hair loss,
- nausea, and
- numbness, tingling, or burning in the hands and feet (peripheral neuropathy).
The most common serious side effect is decreased white blood cell counts or neutropenia. White blood cells are necessary to fight infections; therefore, significantly low levels of white blood cells may increase the risk for serious infections that can lead to hospitalization or death.
Peripheral neuropathy (damage to the nerves of the extremities) is the most common side effect that causes patients to stop taking eribulin. Severe peripheral neuropathy occurred in 8% of patients treated with eribulin. Furthermore, 5% of patients experienced neuropathy lasting more than 1 year, while 22% of patients developed new or worsening neuropathy that did not get better after an average of 269 days.
Eribulin also can cause abnormalities in the electrocardiogram such as QT prolongation and changes in the heartbeat rhythm that can potentially cause death.
Eribulin can damage the kidney or liver. Risk for injury is higher in patients who have pre-existing kidney or liver disease. To avoid serious injury, such patients should be treated with a lower dose of eribulin.
Quick GuideBreast Cancer Diagnosis and Treatment
What is the dosage for eribulin mesylate, Halaven?
The recommended dose of eribulin is 1.4 mg/m2 administered into the vein (intravenously) over 2 to 5 minutes on days 1 and 8 of a 21 day cycle of chemotherapy.
The recommended dose of eribulin in patients with mild liver disease (Child-Pugh A) is 1.1 mg/m2 administered into the vein (intravenously) over 2 to 5 minutes on days 1 and 8 of a 21 day cycle.
The recommended dose of eribulin in patients with moderate liver disease (Child-Pugh B) is 0.7 mg/m2 administered into the vein (intravenously) over 2 to 5 minutes on days 1 and 8 of a 21-day cycle.
The recommended dose of eribulin in patients with moderate or severe kidney disease (creatinine clearance 15-49 ml/min) is 1.1 mg/m2 administered into the vein (intravenously) over 2 to 5 minutes on days 1 and 8 of a 21-day cycle.
The dose of eribulin may need to be decreased or treatment may need to be temporarily or permanently interrupted if patients experience a significant drop in their blood cell counts (red blood cells, white blood cells, and/or platelets) or severe peripheral neuropathy.
Eribulin may be administered undiluted or diluted in 100 ml of 0.9% normal saline (salt water). Eribulin should not be mixed with or administered in the same line as solutions containing dextrose (sugar).
Which drugs or supplements interact with eribulin mesylate, Halaven?
Eribulin may cause abnormal heart beats. Combining eribulin with other drugs with a similar effect on the heart increases the risk of developing abnormal heart beats.
Is eribulin mesylate, Halaven safe to take if I'm pregnant or breastfeeding?
Eribulin has not been adequately evaluated in pregnant women. However, based on the mechanism in which eribulin works in the body, it is expected to cause harm to the unborn baby and therefore, should not be used during pregnancy. In animal studies eribulin caused birth defects in rats. Eribulin is classified as FDA pregnancy risk category D.
It is not known if eribulin is excreted in breast milk. As many drugs enter human milk and can potentially cause harm to the nursing infant, eribulin is not recommended in nursing mothers.
What else should I know about eribulin mesylate, Halaven?
What preparations of eribulin mesylate, Halaven are available?
Solution for intravenous (IV) injection: 1 mg/2 ml. Eribulin is available in single use vials.
How should I keep eribulin mesylate, Halaven stored?
Eribulin should be stored at room temperature, between 15 C to 30 C (59 F to 86 F). Vials should be stored in their original cartons.
After drawing into the syringe, undiluted eribulin can be stored for up to 4 hours at room temperature or for up to 24 hours in the refrigerator (4 C or 40 F).
FDA Prescribing Information
Quick GuideBreast Cancer Diagnosis and Treatment
Daily Health News
Subscribe to MedicineNet's Cancer Report Newsletter
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
- eribulin mesylate (Halaven) Related Diseases
- eribulin mesylate (Halaven) Images & Quizzes
- eribulin mesylate (Halaven) Index
FDA Prescribing Information
Top eribulin mesylate, Halaven Related ArticlesComplete List
Breast Anatomy PictureThe breast refers to the front of the chest or, more specifically, to the mammary gland. See a picture of Breast Anatomy and learn more about the health topic.
Breast BiopsyThere are several types of breast biopsies, which are diagnostic procedures to examine part or all of suspicious breast growth(s). The types of breast biopsies include fine needle aspiration breast biopsy (FNAB), core needle breast biopsy (CNB), vacuum-assisted breast biopsy, and excision breast biopsy (surgery, lumpectomy). The type of breast biopsy procedure depends upon the location and size of the growth(s).
Breast Cancer (Facts, Stages)Breast cancer is an invasive tumor that develops in the mammary gland. Breast cancer is detected via mammograms, breast self-examination (BSE), biopsy, and specialized testing on breast cancer tissue. Treatment of breast cancer may involve surgery, radiation, hormone therapy, chemotherapy, and targeted therapy. Breast cancer risk may be lowered by managing controllable risk factors.
Breast Cancer and Coping With StressBeing diagnosed with breast cancer is stressful. Learning relaxation techniques, exercising, eating well, getting adequate sleep, receiving psychotherapy, and maintaining a positive attitude can help you cope. Creating documents, such as an advance directive, living will, and durable power of attorney will outline your wishes in the event that you are no longer able to make decisions regarding your care.
Breast Cancer and LymphedemaLymphedema is a common chronic, debilitating condition in which excess fluid called lymph collects in tissues and causes swelling in them. It is common after a mastectomy, lumpectomy or breast cancer surgery and radiation therapy.
Breast Cancer SlidesLearn about breast cancer causes, symptoms, tests, recovery, and prevention. Discover the types of treatments such as surgery and drug therapies as well as the survival rate for breast cancer.
Breast Cancer PreventionLifestyle changes, a healthy antioxidant-rich diet, exercise, and weight reduction can help reduce a woman's risk of developing breast cancer. It's important to be aware of how risk factors such as family history, lifestyle factors, breast conditions, radiation therapy, and hormonal factors may influence your chances of developing breast cancer. Mammography and breast self-examinations are crucial steps in breast cancer prevention.
Breast Cancer QuizThis Breast Cancer Quiz features signs, symptoms, facts, causes, common forms, terms, risk factors, statistics, and more. Increase your awareness of breast cancer now!
Breast Lumps In WomenBreast lumps in women can have a variety of causes such as breast inflammation, infection, injuries, cancer, and non-cancerous growths. Breast lumps in women are diagnosed with physical exam, mammogram, ultrasound, MRI, and biopsy. Treatment of breast lumps in women depend on the cause.
Breast Self ExamA woman can use a breast self-exam to check for changes, lumps, or thickenings, in her breasts. Any unusual changes should be reported to the doctor. A breast self-exam is one way to detect lumps that may be cancerous. Early detection and treatment of breast cancer greatly increases the likelihood for survival.
Chemotherapy Treatment for Breast CancerChemotherapy refers to medications that are administered to kill or slow the growth of cancerous cells. Chemotherapy may be given orally or intravenously. Side effects of breast cancer chemotherapy may include nausea, vomiting, hair loss, increased risk of infection, fatigue, and easy bruising. Receiving chemotherapy causes changes in a woman's menstrual cycle.
Genetic Testing for Breast CancerIntensive genetic counseling is required before undergoing genetic tests for breast cancer. During this educational counseling session, the health care provider can fully explain the benefits and risks of genetic testing and answer any questions you may have. You will also be required to sign a consent form prior to participating in any genetic tests. The form is an agreement between you and your doctor, showing that you have discussed the test and how its results might affect your family.
Radiation Therapy for Breast CancerRadiation refers to high-energy rays that are directed at the breast to kill or slow the growth of cancer cells. Radiation reduces the risk of local cancer recurrence in the breast. Potential side effects include skin redness, swelling, peeling, and fatigue. It is necessary to undergo follow-up exams and diagnostic X-rays after completing radiation therapy for breast cancer.